NCT00005910
- Conditions
- Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +16 more
- Locations
-
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States
Clinical trial condition
Adenoma, Islet Cell
Explore clinical trials studying Adenoma, Islet Cell. Study availability and eligibility vary by location and protocol.
81 public trials
26 recruiting studies
Adenoma, Islet Cell trial results
Active, Not Recruiting
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors
NCT03375320
- Conditions
- Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +42 more
- Locations
-
- Katmai Oncology Group Anchorage, Alaska, United States
- Kingman Regional Medical Center Kingman, Arizona, United States
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
Active, Not Recruiting
Multicenter Trial of ESK981 in Patients With Select Solid Tumors
NCT05988918
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +27 more
- Locations
-
- Rogel Cancer Center Ann Arbor, Michigan, United States
- University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States
Active, Not Recruiting
Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors
NCT03074513
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Adenoma, +63 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors
NCT01824875
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +23 more
- Locations
-
- Kaiser Anaheim Medical Center Anaheim, California, United States
- Kaiser Permanente-Deer Valley Medical Center Antioch, California, United States
- Kaiser Permanente Medical Group - Baldwin Park Baldwin Park, California, United States
- Kaiser Foundation Hospital Bellflower, California, United States
Active, Not Recruiting
Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors
NCT03891784
- Conditions
- Adenoma, Adenoma, Islet Cell, Advanced Digestive System Neuroendocrine Neoplasm, +19 more
- Locations
-
- University of Colorado Denver, Colorado, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Active, Not Recruiting
ATRX/DAXX in EUS-FNB Specimens of Pan-NETs
NCT06406387
- Conditions
- Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +10 more
- Locations
-
- University Hospital of Verona Verona, Italy
Active, Not Recruiting
Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors
NCT03600233
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +21 more
- Locations
-
- Chang Gung Memorial Hospital, KaoHsiung Kaohsiung City, Taiwan
- Kaohsiung Medical University Hospital Kaohsiung City, Taiwan
- New Taipei Municipal TuCheng Hospital New Taipei City, Taiwan
- China Medical University Hospital Taichung, Taiwan
Active, Not Recruiting
A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors
NCT06148636
- Conditions
- Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +21 more
- Locations
-
- Holden Comprehensive Cancer Center at the University of Iowa Iowa City, Iowa, United States
Active, Not Recruiting
Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors
NCT05247905
- Conditions
- Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +11 more
- Locations
-
- Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Tower Cancer Research Foundation Beverly Hills, California, United States
- Epic Care-Dublin Dublin, California, United States